Hostname: page-component-cd9895bd7-mkpzs Total loading time: 0 Render date: 2024-12-22T06:43:18.308Z Has data issue: false hasContentIssue false
  • English
  • Français

Introducing a new recruitment approach to sample collection for genetic association studies in opioid dependence

Published online by Cambridge University Press:  16 April 2020

Petra Franke ,
Birgit Wendel ,
Michael Knapp ,
Sibylle G. Schwab ,
Daniela Neef ,
Wolfgang Maier ,
Dieter B. Wildenauer  and
Margret R. Hoehe
Petra Franke*
Affiliation:
Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 25, 53105Bonn, Germany
Birgit Wendel
Affiliation:
Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany
Michael Knapp
Affiliation:
Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany
Sibylle G. Schwab
Affiliation:
Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 25, 53105Bonn, Germany
Daniela Neef
Affiliation:
Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 25, 53105Bonn, Germany
Wolfgang Maier
Affiliation:
Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 25, 53105Bonn, Germany
Dieter B. Wildenauer
Affiliation:
Department of Psychiatry, University of Bonn, Sigmund-Freud-Str. 25, 53105Bonn, Germany
Margret R. Hoehe
Affiliation:
Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany Max Planck Institute for Molecular Genetics, Berlin, Germany
*
*E-mail address: [email protected]
Get access

Abstract

Objective. –

In a modified case–control association study we tested the assumption that two polymorphisms (A118G in exon 1 and IVS2+31 in intron 2) of the human μ-opioid receptor gene (OPRM1) confer susceptibility to opioid dependence.

Methods. –

In contrast to classical case–control studies both groups, opioid dependent cases and non-opioid dependent controls were recruited from individuals who have had access to drugs including opioids and who had been sentenced for violation of the “Dangerous Drugs Act” in Germany.

Results. –

For the two allelic variants of OPRM1 under study we did not find evidence for association with opioid dependence.

Conclusions. –

Despite absence of association we think that this recruitment approach introduced here, is useful since it putatively offers a more adequate matching for case–control association studies of opioid dependent individuals.

Keywords

AddictionOpioidsOPRM1PolymorphismCase–control study
Type
Original article
Information
European Psychiatry , Volume 18 , Issue 1 , February 2003 , pp. 18 - 22
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Enoch, MA, Goldman, DGenetics of alcoholism and substance abuse. Addict Disord 1999;22:289–99.Google ScholarPubMed
Kendler, KS, Karkowski, LM, Neale, MC, Prescott, CAIllicit psycho-active substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry 2000; 57:261–9.CrossRefGoogle Scholar
Sora, I, Takahashi, N, Funada, M, Ujike, H, Revay, RS, Donovan, DMet al. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci USA 1997;94:1544–9.CrossRefGoogle ScholarPubMed
Uhl, GR. Molecular genetics of substance abuse vulnerability: a current approach. Neuropsychopharmacol 1999;20:3–9.CrossRefGoogle ScholarPubMed
Uhl, GR, Sora, I, Wang, ZThe µ opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc Natl Acad Sci USA 1999;96:7752–5.CrossRefGoogle Scholar
Chen, Y, Fan, Y, Liu, J, Mestek, A, Tian, M, Kozak, CA, Yu, LMolecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett 1994;27: 279–83.CrossRefGoogle Scholar
Wang, JB, Johnson, PS PersicoAM, Hawkins, AL, Griffin, CA, Uhl, GRHuman mu opiate receptor. cDNA and genomic clones, pharmaco-logic characterization and chromosomal assignment. FEBS Lett 1994;338:217–22.CrossRefGoogle Scholar
Mayer, P, Höllt, VAllelic and somatic variations in the endogenous opioid system of humans. Pharmacol Ther 2001;91:167–77.CrossRefGoogle ScholarPubMed
Gelernter, J, Kranzler, H, Cubells, JGenetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry 1999;4:476–83.CrossRefGoogle ScholarPubMed
Bond, C, LaForge, KS, Tian, M, Melia, D, Zhang, S, Borg, Let al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters b-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998;95:9608–13.CrossRefGoogle ScholarPubMed
Hoehe, MR, Köpke, K, Wendel, B, Rohde, K, Flachmeier, C, Kidd, KKet al. Sequence variability and candidate gene analysis in complex disease: association of µ opioid receptor gene variation with substance dependence. Hum Mol Genet 2000;9:2895–908.CrossRefGoogle Scholar
Buchholz, KK, Cadoret, R, Cloninger, CR, Dinwiddie, SH, Hessel-brock, VM, Nurnberger, JIet al. A new, semistructured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994;55:149–58.CrossRefGoogle Scholar
Keppel, S, Dilg, C, Franke, PTest-Retest und Interrater-Reliabilität des Semistrukturierten Interviews zur Genese von Alkohol- und Drogen-abhängigkeit (SIGAD). Suchtmedizin 2001;3:217–24.Google Scholar
American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association; 1987 [Revised].Google Scholar
Wendel, B, Hoehe, MRThe human mu opioid receptor gene: 5’ regulatory and intronic sequences. J Mol Med 1998;76:525–32.CrossRefGoogle ScholarPubMed
Devlin, B, Risch, NA comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995;29:311–22.CrossRefGoogle ScholarPubMed
Bergen, AW, Kokoszka, J, Peterson, R, Long, JC, Virkkunen, M, Lin-noila, Met al. Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry 1997;2:490–4.CrossRefGoogle ScholarPubMed
Sander, T, Gscheidel, N, Wendel, B, Samochowiec, J, Smolka, M, Rom-melspacher, Het al. Human mu-opioid receptor variation and alcohol dependence. Alcohol Clin Exp Res 1998;22:2108–10.Google ScholarPubMed
Town, T, Abdullah, L, Crawford, F, Schinka, J, Ordorica, PI, Francis, Eet al. Association of a functional µ-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet 1999;88:458–61.3.0.CO;2-S>CrossRefGoogle Scholar
Franke, P, Wang, T, Nothen, MM, Knapp, M, Neidt, H, Albrecht, Set al. Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet 2001;105:114–9.3.0.CO;2-L>CrossRefGoogle ScholarPubMed
Szeto, CYK, Tang, NLS, Lee, DTS, Stadlin, AAssociation between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport 2001;12:1103–6.CrossRefGoogle ScholarPubMed
Shi, J, Hui, L, Xu, Y, Wang, F, Huang, W, Hu, GSequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat 2002;19:459–65.CrossRefGoogle ScholarPubMed
Reich, EE, Goldstein, DBDetecting association in a case-control study while correcting for population stratification. Genet Epidemiol 2001;20:4–16.3.0.CO;2-T>CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.